Silver pared most of its gains in the past five days due to US election uncertainty. It reached a low of $32.24 and is currently trading around $32.58.The short-term trend remains positive as long as support at $2.18 (200-day EMA) holds.
The National People's Congress (NPC) of China is meeting from November 4 to 8, 2024, to discuss a possible fiscal stimulus package. This meeting coincides with the U.S. presidential election, which could impact China's decisions. Estimates for the stimulus package vary, ranging from 2 trillion yuan (about $280 billion) to 10 trillion yuan (around $1.4 trillion). The package may include special bonds for debt swaps and bank recapitalization.
Markets eye US Fed monetary policy on Nov 7th for further movement.
The gold-silver ratio is at 84.02, indicating that gold has outperformed silver recently. A ratio above 80 might suggest that silver could be a more appealing investment compared to gold.
For trading, the major level to watch is $32.75. Silver is currently below key moving averages, with near-term support at $32.18. If it drops below this, it could target $31.30/$30.70/$30. On the upside, immediate resistance is at $32.75, and breaking this could lead to targets of $33/$33.60/$34/$34.50/$34.50/$34.73.
It may be a good strategy to buy on dips around $32, with a stop-loss at $31.30 and a target price of $34.70.


Gold Cracks Below $4,500 as Safe-Haven Shine Fades; Technical Breakdown Signals Sell-on-Rallies Toward $4,000
Detroit’s high property taxes are driving a housing affordability crisis – how can city leaders bring down costs?
Cuba needs a long-term solution to its energy crisis
Morgan Stanley Names Top AI Security and Data Center Stocks for 2026
Silver Sheds Gains in Gold’s Wake as Bears Probe Key $74.50 Support; Sell-on-Rallies Eyes $70
Rice feeds billions of people – but its role in fueling climate change is growing
Gold Cracks Below $4,500 as Safe-Haven Shine Fades; Technical Breakdown Signals Sell-on-Rallies Toward $4,000
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
Global Bond Selloff Pressures Stocks as Rising Oil Prices Fuel Inflation Fears 



